Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
15.63
+0.18 (1.17%)
At close: Aug 1, 2025, 4:00 PM
15.63
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:20 PM EDT

Travere Therapeutics Stock Forecast

Stock Price Forecast

The 15 analysts that cover Travere Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $33.33, which forecasts a 113.24% increase in the stock price over the next year. The lowest target is $20 and the highest is $47.

Price Target: $33.33 (+113.24%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$20$33.33$31$47
Change+27.96%+113.24%+98.34%+200.70%
* Price targets were last updated on Jul 1, 2025.

Analyst Ratings

The average analyst rating for Travere Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy555566
Buy888888
Hold112222
Sell000000
Strong Sell000000
Total141415151616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$30
Strong BuyInitiates$30+91.94%Jul 1, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$35$32
Strong BuyMaintains$35$32+104.73%Jun 11, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$30
Strong BuyInitiates$30+91.94%Jun 11, 2025
Wedbush
Wedbush
Buy
Reiterates
$30
BuyReiterates$30+91.94%May 16, 2025
Wedbush
Wedbush
Buy
Reiterates
$30
BuyReiterates$30+91.94%May 2, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
400.16M
from 233.18M
Increased by 71.61%
Revenue Next Year
574.03M
from 400.16M
Increased by 43.45%
EPS This Year
-1.11
from -4.08
EPS Next Year
0.45
from -1.11
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
198.32M131.84M109.46M145.24M233.18M400.16M574.03M758.16M
Revenue Growth
13.11%-33.52%-16.97%32.69%60.55%71.61%43.45%32.08%
EPS
-3.56-3.01-4.37-1.50-4.08-1.110.452.33
EPS Growth
-------422.12%
Forward PE
------35.076.72
No. Analysts
-----171712
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High466.6M835.7M1.2B
Avg400.2M574.0M758.2M
Low327.2M441.2M578.2M

Revenue Growth

Revenue Growth20252026202720282029
High
100.1%
108.8%
106.3%
Avg
71.6%
43.5%
32.1%
Low
40.3%
10.3%
0.7%

EPS Forecast

EPS20252026202720282029
High-0.533.376.29
Avg-1.110.452.33
Low-1.99-1.200.25

EPS Growth

EPS Growth20252026202720282029
High--
1,311.0%
Avg--
422.1%
Low--
-45.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.